Does PALIVIZUMAB Cause Dyspnoea? 466 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 466 reports of Dyspnoea have been filed in association with PALIVIZUMAB (Synagis). This represents 4.1% of all adverse event reports for PALIVIZUMAB.
466
Reports of Dyspnoea with PALIVIZUMAB
4.1%
of all PALIVIZUMAB reports
10
Deaths
370
Hospitalizations
How Dangerous Is Dyspnoea From PALIVIZUMAB?
Of the 466 reports, 10 (2.1%) resulted in death, 370 (79.4%) required hospitalization, and 13 (2.8%) were considered life-threatening.
Is Dyspnoea Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PALIVIZUMAB. However, 466 reports have been filed with the FAERS database.
What Other Side Effects Does PALIVIZUMAB Cause?
Respiratory syncytial virus infection (1,692)
Pyrexia (1,055)
Death (856)
Bronchiolitis (724)
Cough (665)
Pneumonia (657)
Nasopharyngitis (462)
Vomiting (445)
Influenza (398)
Product dose omission issue (381)
What Other Drugs Cause Dyspnoea?
ALBUTEROL (21,856)
TREPROSTINIL (16,348)
AMBRISENTAN (13,367)
PREDNISONE (12,830)
BUDESONIDE\FORMOTEROL (11,158)
TIOTROPIUM (10,863)
ADALIMUMAB (10,547)
DUPILUMAB (10,310)
FLUTICASONE\SALMETEROL (9,783)
MEPOLIZUMAB (9,192)
Which PALIVIZUMAB Alternatives Have Lower Dyspnoea Risk?
PALIVIZUMAB vs PALONOSETRON
PALIVIZUMAB vs PAMIDRONATE
PALIVIZUMAB vs PAMIDRONIC ACID
PALIVIZUMAB vs PANCRELIPASE
PALIVIZUMAB vs PANCRELIPASE AMYLASE\PANCRELIPASE LIPASE\PANCRELIPASE PROTEASE